Impax Asset Management Group PLC Repligen Corp Transaction History

Impax Asset Management Group PLC

$23 Billion
Q3 2024

A detailed history of Impax Asset Management Group PLC transactions in Repligen Corp stock. As of the latest transaction made, Impax Asset Management Group PLC holds 1,058,169 shares of RGEN stock, worth $147 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares

1,058,169

Previous 1,058,169 -0.0%

Holding current value

$147 Million

Previous $157 Million -0.0%

% of portfolio

0.69%

Previous 0.69%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$119.79 - $167.35 $8.23 Million - $11.5 Million	-68,709 Reduced 6.1%	1,058,169 $157 Million
Q2 2024 Nov 08, 2024	BUY	$120.0 - $182.95 $8.25 Million - $12.6 Million	68,709 Added 6.49%	1,126,878 $142 Million
Q2 2024 Aug 05, 2024	BUY	$120.0 - $182.95 $53.5 Million - $81.6 Million	445,858 Added 65.47%	1,126,878 $142 Million
Q1 2024 Apr 30, 2024	SELL	$170.78 - $208.42 $39.6 Million - $48.3 Million	-231,801 Reduced 25.39%	681,020 $125 Million
Q4 2023 Jan 26, 2024	SELL	$114.17 - $185.35 $6.83 Million - $11.1 Million	-59,848 Reduced 6.15%	912,821 $164 Million
Q3 2023 Nov 07, 2023	SELL	$138.78 - $176.51 $5.47 Million - $6.95 Million	-39,398 Reduced 3.89%	972,669 $155 Million
Q2 2023 Aug 07, 2023	BUY	$138.42 - $180.31 $20.2 Million - $26.3 Million	145,688 Added 16.82%	1,012,067 $143 Million
Q1 2023 May 10, 2023	BUY	$154.26 - $198.1 $7.02 Million - $9.02 Million	45,527 Added 5.55%	866,379 $146 Million
Q4 2022 Feb 09, 2023	BUY	$162.42 - $220.56 $10.8 Million - $14.7 Million	66,751 Added 8.85%	820,852 $139 Million
Q3 2022 Nov 08, 2022	SELL	$160.42 - $256.21 $15.4 Million - $24.6 Million	-96,050 Reduced 11.3%	754,101 $140 Million
Q2 2022 Aug 11, 2022	SELL	$140.68 - $188.02 $6.07 Million - $8.11 Million	-43,160 Reduced 4.83%	850,151 $137 Million
Q1 2022 May 16, 2022	BUY	$161.19 - $257.96 $12.9 Million - $20.7 Million	80,299 Added 9.88%	893,311 $167 Million
Q4 2021 Feb 14, 2022	BUY	$247.59 - $304.47 $48.4 Million - $59.5 Million	195,300 Added 31.62%	813,012 $214 Million
Q3 2021 Nov 12, 2021	SELL	$194.77 - $324.21 $38.7 Million - $64.5 Million	-198,804 Reduced 24.35%	617,712 $178 Million
Q2 2021 Aug 05, 2021	BUY	$165.87 - $220.95 $8.35 Million - $11.1 Million	50,362 Added 6.57%	816,516 $162 Million
Q1 2021 May 14, 2021	BUY	$180.37 - $226.26 $37 Million - $46.5 Million	205,306 Added 36.61%	766,154 $148 Million
Q4 2020 Feb 16, 2021	BUY	$148.08 - $206.57 $40.8 Million - $57 Million	275,711 Added 96.69%	560,848 $107 Million
Q3 2020 Nov 12, 2020	SELL	$122.51 - $158.27 $423,762 - $547,455	-3,459 Reduced 1.2%	285,137 $41.6 Million
Q2 2020 Aug 14, 2020	BUY	$94.33 - $140.48 $11.8 Million - $17.6 Million	125,496 Added 76.94%	288,596 $35.7 Million
Q1 2020 May 15, 2020	BUY	$84.96 - $109.14 $13.9 Million - $17.8 Million	163,100 New	163,100 $15.6 Million

Others Institutions Holding RGEN

# of Institutions

486

Shares Held

54.3M

Call Options Held

341K

Put Options Held

235K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.71B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Impax Asset Management Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Impax Asset Management Group PLC with notifications on news.

Account

Impax Asset Management Group PLC Repligen Corp Transaction History